Skip to content

What Peptides Are

A foundational introduction to peptides — what they are, how they differ from proteins and drugs, and why they matter for health.

Module 18 min read

The Basics

Peptides are short chains of amino acids — the same building blocks that make up proteins. While proteins are long chains (typically hundreds or thousands of amino acids), peptides are shorter, usually between 2 and 50 amino acids. This smaller size gives peptides unique properties: they can act as precise signaling molecules, telling cells what to do without the complexity of larger proteins. Your body naturally produces thousands of peptides that regulate everything from growth and metabolism to immune function and mood. When we talk about 'peptide therapy,' we are typically referring to synthetic versions of these natural signaling molecules, or novel peptides designed to interact with specific biological pathways.

How Peptides Differ from Traditional Drugs

Traditional pharmaceutical drugs are usually small chemical molecules that interact with biological targets. Peptides sit in a middle ground between small-molecule drugs and large biological therapies (like antibodies). They tend to be more specific than small molecules but more versatile than large biologics. Key differences include: peptides often mimic natural biological signals, they tend to have fewer off-target effects than small molecules, they are usually broken down into amino acids (natural building blocks) rather than foreign metabolites, and they often require injection because they would be digested if taken orally.

Why Peptides Are Gaining Attention

Several factors have driven growing interest in peptides: advances in synthesis technology have made them more accessible, research has identified numerous peptide-mediated pathways relevant to health optimization, and there is growing demand for therapies that work with the body's natural systems rather than overriding them. However, it is crucial to approach peptides with appropriate caution. Many are still in early stages of research, regulatory status varies widely, and quality control can be a significant concern with non-pharmaceutical sources.

Important Context

Not all peptides are created equal in terms of evidence. Some, like Tesamorelin and PT-141, are FDA-approved for specific indications. Others have extensive international clinical data. Many are supported primarily by animal studies. And some are very early-stage research compounds with minimal safety data. Throughout this resource, we grade evidence levels and highlight what is known and unknown for each compound. This transparency is essential for making informed decisions.

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician